Trading Signals: SGMO Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 13, 2022)(Sangamo Therapeutics, Inc. )
| SGMO latest price $11.9900 (2.04%) ($11.9900 - $12.0000) on Sun. Jun. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.73% (three month average) | RSI | 65 | Latest Price | $11.9900(2.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SGMO advances 1.1% a day on average for past five trading days. | Weekly Trend | SGMO advances 0.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGMO advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting SGMO price | SGMO will decline at least -1.365% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.365% (StdDev 2.73%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $11.67(2.74%) | 10 Day Moving Average | $11.54(3.9%) | 20 Day Moving Average | $11.37(5.45%) | To recent high | -5.2% | To recent low | 17.6% | Market Cap | $N/A | | | | Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Brisbane, CA. |